Government-Supported Incentives Could Prompt More Research Into New Antibacterial Drugs, Report Says

CIDRAP News: Market-entry rewards seen as good option for getting new antibiotics
“A system in which drug companies would win sizable government payments for bringing new antibacterial drugs to market may be the best of various possible ways to encourage the development of such products by boosting their profitability, according to a new report from the Transatlantic Task Force on Antimicrobial Resistance (TATFAR). The report, published [Wednesday] in Clinical Infectious Diseases, looks at six ‘pull’ incentives for promoting the development of new antibacterial drugs in the face of rising antimicrobial resistance worldwide…” (Roos, 6/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.